The Stupidest Thing in American Health Care? Failing to Tackle Obesity Early.
It takes a very particular kind of political brainworm to look at a country where nearly half the population is obese, where Medicare and Medicaid hemorrhage cash treating diabetes, heart disease, stroke, and cancer — and say: let’s not pay for the medicine that actually fixes the root problem. And yet, here we are. GLP-1 […]
Semaglutide helps heart regardless of how much weight lost, study reveals
Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much weight people lose while taking the drug, according to a new study led by a UCL researcher.
SCIENCE: Study finds GLP-1 drugs may help prevent risks from sleep apnea.
SCIENCE: Study finds GLP-1 drugs may help prevent risks from sleep apnea.
GLP-1 Medications, Like Ozempic, May Help To Slow Or Even Reverse Aging According To New Study
Shutterstock GLP-1 drugs such as Ozempic have been shown to be extremely effective at helping diabetics manage their blood sugar, and almost anyone else to lose weight and keep it off. These drugs have also been shown to help stop addictions of all types in many people. A new study performed by TruDiagnostic has one […]
STAT+: Pharmalittle: We’re reading about a new Trump drug-pricing probe, Novo’s board shake-up, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we are firing up the coffee kettle and invite you […]
STAT+: Novo Foundation ousts board in power struggle
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we talk about how startups are looking for new ways to price drugs, particularly GLP-1s, see how tracking circulating tumor DNA holds promise in cancer treatment, and more. The need-to-know this morning […]
Why Everything From Perfume to Soap Smells Like Food Now
As demand for products scented like vanilla, pistachio and other edible indulgences soars, some GLP-1 users say there’s a link to their changed eating habits.
Among T2D Drugs, GLP-1s Top Others for Reducing CV Events
A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against cardiovascular events, followed by SGLT2i and two older drug classes. Medscape Medical News
More and more workers are using weight loss drugs. It’s costing their employers a fortune – CNN
More and more workers are using weight loss drugs. It’s costing their employers a fortune CNN Ozempic for All The Atlantic Lopez: Expanding access to anti-obesity drugs a win-win Boston Herald What To Do When Insurance Won’t Cover Your GLP-1 Prescription NewBeauty Perspectives from Employers on the Costs and Issues Associated with Covering GLP-1 Agonists for Weight Loss KFF
STAT+: Companies tout a novel payment model for obesity drugs, other medications in drive to lower costs
As pharma companies and President Trump tout initiatives to sell branded medications directly to cash-paying consumers, some entrepreneurs have seized on a potential business opportunity — pitching a new model for employers to help their workers pay for medications without using insurance. Take the blockbuster obesity treatments Wegovy and Zepbound, for example. Many employers don’t […]